- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02142452
Cardiovascular Health in Postpartum Women Diagnosed With Excessive Gestational Weight Gain
March 16, 2021 updated by: Sandra Anping Tsai, Stanford University
The investigators will test the efficacy of a tailored behavioral lifestyle modification program to support cardiovascular health in postpartum women with excessive gestational weight gain.
This program will include a mobile health texting component postpartum to support changes in nutrition and physical activity.
The investigators will randomize women into either the control arm (usual care) or the intervention (usual care + mobile health program postpartum).
The women will be recruited during their 3rd trimester once they have been identified as gaining too much weight according to the 2009 IOM guidelines during pregnancy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
55
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford Hospital and Clinics
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Pregnant woman diagnosed with excessive gestational weight at 24 weeks gestation or later
- Age 18 years or older
- English-speaking, and willing and able to participate in the proposed intervention.
Exclusion Criteria:
- Inability to provide informed consent and/or an inability to speak, read, or understand English
- Primary residence is outside of the immediate catchment area of 10 miles
- Physical or mental challenges that precludes them from exercising or returning for scheduled study follow ups
- Concurrent enrollment in another behavior modification program
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: mobile health intervention
Behavioral intervention.
Women with excessive weight gain in pregnancy will be recruited in their 3rd trimester.
They will begin with a 5 week group session on weight management.
After they deliver the baby, they will begin receiving text messages supporting behavior change they learned in their 3rd trimester.
They will follow up at 6 weeks postpartum and 4 months postpartum.
|
Behavioral intervention will include a group class for women in their 3rd trimester followed by a mobile texting program to support behavior change postpartum.
|
Placebo Comparator: Control Group
Women will receive usual prenatal care from their OB.
Postpartum, they will receive a monthly newsletter relevant to the new mother on her nutrition and physical activity.
They will be followed at 6 weeks postpartum and 4 months postpartum.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
BMI (body mass index)
Time Frame: 4 months postpartum
|
A mobile Health intervention tailored for the 30 postpartum mother and grounded in behavioral change theory will be associated with significantly more reduction in BMI than 30 women not enrolled in the intervention.
|
4 months postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiovascular health metrics
Time Frame: 4 months postpartum
|
(1) Examine changes in cardiovascular health metrics (fasting glucose, fasting insulin, and BP) and markers of inflammation (hs-CRP) verses control group (2) We will evaluate changes in perceived nutrition, physical activity, and weight-loss self-efficacy; self-efficacy has been shown to be a direct predictor of behavior (3) measure the effects of breastfeeding support on the length of time a mother breastfeeds verse the control group.
|
4 months postpartum
|
Change in self efficacy score based on behavioral self-efficacy scale
Time Frame: 4 months postpartum
|
We will measure changes in pre- and post-intervention self-efficacy of all women in intervention and control arms.
|
4 months postpartum
|
Cardiovascular health metrics
Time Frame: 4 months postpartum
|
We will evaluate changes in perceived nutrition, physical activity, and weight-loss self-efficacy; self-efficacy has been shown to be a direct predictor of behavior
|
4 months postpartum
|
Cardiovascular health metric
Time Frame: 4 months postpartum
|
Measure the effects of breastfeeding support on the length of time a mother breastfeeds verse the control group.
|
4 months postpartum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sandra A Tsai, MD, Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2014
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
March 1, 2016
Study Registration Dates
First Submitted
May 8, 2014
First Submitted That Met QC Criteria
May 19, 2014
First Posted (Estimate)
May 20, 2014
Study Record Updates
Last Update Posted (Actual)
March 17, 2021
Last Update Submitted That Met QC Criteria
March 16, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 28810
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Turku University HospitalUniversity of TurkuCompleted
-
Hopital Antoine BeclereUnknown
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
Clinical Trials on behavioral intervention
-
M.D. Anderson Cancer CenterActive, not recruitingObesity-Related Malignant NeoplasmUnited States
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Brown... and other collaboratorsRecruiting
-
VA Office of Research and DevelopmentRecruiting
-
Pennington Biomedical Research CenterThe Coca-Cola CompanyCompletedParent-targeted Mobile Phone Based Intervention to Increase Physical Activity in Children (P-Mobile)Physical ActivityUnited States
-
University of FloridaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
New York State Psychiatric InstituteCompletedPostpartum DepressionUnited States
-
VA Office of Research and DevelopmentCompleted
-
National Taiwan University HospitalUnknown
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer... and other conditionsUnited States
-
Roswell Park Cancer InstituteRecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States